Leukemic reticuloendotheliosis.Report of a case with peripheral blood remission on androgen therapy
- 1 May 1978
- Vol. 41 (5) , 1964-1966
- https://doi.org/10.1002/1097-0142(197805)41:5<1964::aid-cncr2820410541>3.0.co;2-j
Abstract
Leukemic reticuloendotheliosis (LRE) has been generally considered to be poorly responsive to therapy other than splenectomy. The patient presented below developed a complete peripheral blood remission after prolonged therapy with an androgen (oxymetholone). There is very little published experience with androgen therapy in LRE. The experience with this patient suggests that androgens may produce a clinical remission by inducing significant improvement in the peripheral blood in some patients with this disease.This publication has 12 references indexed in Scilit:
- Hairy-Cell LeukemiaNew England Journal of Medicine, 1977
- Leukemic ReticuloendotheliosisArchives of internal medicine (1960), 1976
- Leukemic reticuloendotheliosis. A clinicopathologic study with review of the literatureThe American Journal of Medicine, 1974
- Hairy cell leukemia (leukemic reticuloendotheliosis).I. A clinical pathologic study of 21 patientsCancer, 1974
- Leukaemic Reticuloendotheliosis (‘Hairy’ Cell Leukaemia): A Distinct Clinico‐Pathological EntityBritish Journal of Haematology, 1974
- Leukemic ReticuloendotheliosisArchives of internal medicine (1960), 1972
- Leukemic ReticuloendotheliosisBlood, 1971
- Tartrate-Resistant Acid Phosphatase Isoenzyme in the Reticulum Cells of Leukemic ReticuloendotheliosisNew England Journal of Medicine, 1971
- Androgens and ErythropoiesisArchives of internal medicine (1960), 1961
- Leukemic ReticuloendotheliosisBlood, 1958